Bio-logic's brain monitor cleared for US sale:
This article was originally published in Clinica
Executive Summary
The FDA has cleared a new brain monitoring device which records signals from more sites on the brain than existing devices and could be used for more accurate epilepsy monitoring. The Ceegraph device has 132 channels for measuring routine electroencephalograms and for epilepsy and ambulatory monitoring. Bio-logic Systems, which will launch the device in April, said the $40,000 system will compete in the $20 million long term epilepsy monitoring market.